Key Points of the Measures for the Monitoring and Re-evaluation of Medical Device Adverse Events (State Administration for Market Regulation and National Health Commission Order No. 1)

The Measures for the Monitoring and Re-evaluation of Medical Device Adverse Events (Order No. 1), jointly issued by the SAMR and National Health Commission, took effect on January 1, 2019, establishing a tiered reporting and re-evaluation system for post-market adverse events.

Read More